Literature DB >> 1654516

Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.

V Misík1, A Stasko, D Gergeĺ, K Ondrias.   

Abstract

Nifedipine [1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic+ ++ acid dimethyl ester] and nimodipine [1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic+ ++ acid 2-methoxyethyl 1-methylethyl ester], incorporated into diheptanoylphosphatidylcholine liposomes, which were used as a drug carrier system, slightly inhibited lipid peroxidation (induced by tert-butylhydroperoxide and Fe2+) in rat heart homogenate. Illumination of nimodipine had no effect on its antioxidant potency, whereas illuminated nifedipine was several times more effective than nonilluminated drug. On illumination, nifedipine converts to 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester (NTP). NTP formed stable radicals when interacting with the rat heart homogenate and dioleoylphosphatidylcholine, as detected by EPR spectroscopy. No radical formation was observed if nonilluminated nifedipine and nimodipine or illuminated nimodipine were used. The spin density of the unpaired electron in the NTP-adduct was centered on the nitrogen derived from its nitroso group. The motion of the NTP-adduct radical was restricted, indicating that the radicals were located in the membrane of the homogenate and not in the buffer system. Only NTP (not nifedipine or nimodipine) was effective in trapping free radicals formed by the thermal or photoinduced decomposition of 2,2'-azobisisobutyronitrile and radicals formed by photolysis of di-tert-butylperoxide. The antioxidant and spin-trapping properties of NTP in our systems were attributed to its nitroso group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654516

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

Review 1.  Preparations of C-nitroso compounds.

Authors:  Brian G Gowenlock; George B Richter-Addo
Journal:  Chem Rev       Date:  2004-07       Impact factor: 60.622

2.  Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.

Authors:  Takumi Sakurada; Keisuke Ishizawa; Masaki Imanishi; Yuki Izawa-Ishizawa; Shoko Fujii; Erika Tominaga; Teppei Tsuneishi; Yuya Horinouchi; Yoshitaka Kihira; Yasumasa Ikeda; Shuhei Tomita; Ken-ichi Aihara; Kazuo Minakuchi; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-14       Impact factor: 3.000

3.  Effect of illuminated nifedipine, a potent antioxidant, on intestinal and vascular smooth muscles.

Authors:  V Bauer; V V Rekalov; I Juránek; D Gergel; P Bohov
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 4.  1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.

Authors:  Astrida Velena; Neven Zarkovic; Koraljka Gall Troselj; Egils Bisenieks; Aivars Krauze; Janis Poikans; Gunars Duburs
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

5.  Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.

Authors:  Keisuke Ishizawa; Yuki Izawa-Ishizawa; Noriko Yamano; Maki Urushihara; Takumi Sakurada; Masaki Imanishi; Shoko Fujii; Asami Nuno; Licht Miyamoto; Yoshitaka Kihira; Yasumasa Ikeda; Shoji Kagami; Hiroyuki Kobori; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.